Ashley Ringrose

467 total citations
6 papers, 326 citations indexed

About

Ashley Ringrose is a scholar working on Dermatology, Hematology and Genetics. According to data from OpenAlex, Ashley Ringrose has authored 6 papers receiving a total of 326 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Dermatology, 3 papers in Hematology and 2 papers in Genetics. Recurrent topics in Ashley Ringrose's work include Chronic Myeloid Leukemia Treatments (3 papers), Cutaneous lymphoproliferative disorders research (3 papers) and T-cell and Retrovirus Studies (2 papers). Ashley Ringrose is often cited by papers focused on Chronic Myeloid Leukemia Treatments (3 papers), Cutaneous lymphoproliferative disorders research (3 papers) and T-cell and Retrovirus Studies (2 papers). Ashley Ringrose collaborates with scholars based in Canada, United States and France. Ashley Ringrose's co-authors include Xiaoyan Jiang, Ann Lin, Youwen Zhou, Emily M. Pang, Andrew P. Weng, Xiaojiang Li, Irene Li, Ali G. Turhan, Xiao‐Jiang Li and Guoqing Sheng and has published in prestigious journals such as The Journal of Experimental Medicine, Blood and Leukemia.

In The Last Decade

Ashley Ringrose

6 papers receiving 326 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ashley Ringrose Canada	5	182	90	82	46	33	6	326
Ali Amin Asnafi Iran	10	209 1.1×	69 0.8×	73 0.9×	75 1.6×	35 1.1×	35	350
Luk Cox Belgium	9	115 0.6×	195 2.2×	97 1.2×	59 1.3×	22 0.7×	12	432
Tung Wynn United States	11	119 0.7×	60 0.7×	88 1.1×	17 0.4×	11 0.3×	23	306
K Sugita Japan	10	224 1.2×	142 1.6×	58 0.7×	80 1.7×	14 0.4×	22	448
Monique Silvy France	13	207 1.1×	134 1.5×	86 1.0×	27 0.6×	78 2.4×	30	516
Jun Kuyama Japan	9	198 1.1×	93 1.0×	40 0.5×	101 2.2×	12 0.4×	17	327
Agnès Charpentier France	7	161 0.9×	104 1.2×	145 1.8×	44 1.0×	13 0.4×	13	322
Kamal Chamoun United States	9	134 0.7×	122 1.4×	128 1.6×	34 0.7×	29 0.9×	32	337
Alexis Talbot France	11	111 0.6×	191 2.1×	53 0.6×	86 1.9×	41 1.2×	46	409
Gradimir Janković Serbia	13	246 1.4×	102 1.1×	209 2.5×	47 1.0×	20 0.6×	50	437

Countries citing papers authored by Ashley Ringrose

Since Specialization

Citations

This map shows the geographic impact of Ashley Ringrose's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashley Ringrose with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashley Ringrose more than expected).

Fields of papers citing papers by Ashley Ringrose

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashley Ringrose. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashley Ringrose. The network helps show where Ashley Ringrose may publish in the future.

Co-authorship network of co-authors of Ashley Ringrose

This figure shows the co-authorship network connecting the top 25 collaborators of Ashley Ringrose. A scholar is included among the top collaborators of Ashley Ringrose based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashley Ringrose. Ashley Ringrose is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Jiang, Xiaoyan, Donna L. Forrest, Franck E. Nicolini, et al.. (2010). Properties of CD34+ CML stem/progenitor cells that correlate with different clinical responses to imatinib mesylate. Blood. 116(12). 2112–2121. 46 indexed citations

2.

Ringrose, Ashley, et al.. (2009). Identification of tyrosine kinase, HCK, and tumor suppressor, BIN1, as potential mediators of AHI-1 oncogene in primary and transformed CTCL cells. Blood. 113(19). 4646–4655. 31 indexed citations

3.

Zhao, Yun, Ashley Ringrose, Ann Lin, et al.. (2008). AHI-1 interacts with BCR-ABL and modulates BCR-ABL transforming activity and imatinib response of CML stem/progenitor cells. The Journal of Experimental Medicine. 205(11). 2657–2671. 53 indexed citations

4.

Ringrose, Ashley, Youwen Zhou, Emily M. Pang, et al.. (2006). Evidence for an oncogenic role of AHI-1 in Sezary syndrome, a leukemic variant of human cutaneous T-cell lymphomas. Leukemia. 20(9). 1593–1601. 26 indexed citations

5.

Zhou, Leon, Ashley Ringrose, Ann Lin, & Xiaoyan Jiang. (2006). Deregulated Expression of a Novel Oncogene, Ahi-1, in Murine Hematopoietic Cells Confers a Proliferative Advantage In Vitro and Leukemogenic Activity In Vivo and Enhances the Effects of BCR-ABL.. Blood. 108(11). 388–388. 2 indexed citations

6.

Ringrose, Ashley, Youwen Zhou, Emily M. Pang, et al.. (2005). Stable Suppression of a Novel Oncogene, AHI-1, in Human Cutaneous T-Cell Leukemia Cells Normalizes Its Transforming Activity In Vitro and In Vivo and Aberrant Expression of AHI-1 Is Also Present in Leukemic Sezary Cells from Patients with Sezary Syndrome.. Blood. 106(11). 2605–2605. 168 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact